Angle PLC | Balance Sheet

Fiscal year is May-April. All values GBP Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,898.00
8,443.00
3,764.00
5,536.00
7,645.00
Total Accounts Receivable
181.00
763.00
545.00
1,975.00
2,975.00
Inventories
52.00
197.00
376.00
665.00
599.00
Other Current Assets
147.00
245.00
253.00
-
-
Total Current Assets
4,278.00
9,648.00
4,938.00
8,176.00
11,219.00
Net Property, Plant & Equipment
139.00
423.00
455.00
824.00
1,475.00
Long-Term Note Receivable
601.00
-
-
-
-
Intangible Assets
1,142.00
1,149.00
1,346.00
1,918.00
5,588.00
Total Assets
6,160.00
11,220.00
6,739.00
10,918.00
18,282.00
Accounts Payable
92.00
218.00
417.00
980.00
2,398.00
Other Current Liabilities
553.00
913.00
1,087.00
1,132.00
-
Total Current Liabilities
645.00
1,131.00
1,504.00
2,112.00
2,398.00
Total Liabilities
645.00
1,131.00
1,504.00
2,112.00
2,398.00
Common Equity (Total)
5,922.00
10,852.00
6,115.00
9,525.00
16,538.00
Total Shareholders' Equity
5,922.00
10,852.00
6,115.00
9,525.00
16,538.00
Total Equity
5,515.00
10,089.00
5,235.00
8,806.00
15,884.00
Liabilities & Shareholders' Equity
6,160.00
11,220.00
6,739.00
10,918.00
18,282.00
Accumulated Minority Interest
407.00
763.00
880.00
719.00
654.00

About Angle

View Profile
Address
The Surrey Research Park
Guildford Surrey GU2 7YD
United Kingdom
Employees -
Website http://angleplc.com
Updated 07/08/2019
ANGLE Plc operates as a holding company, through its subsidiaries engages in providing products in cancer diagnostics and foetal health. Its main product is the Parsortix cell separation system, which can capture very rare cells from blood. The company was founded by Andrew D.